Status:
COMPLETED
Prognostic Impact of Admission Glucose Level in Septic Patients Admitted to the Intensive Care Unit
Lead Sponsor:
Meir Medical Center
Conditions:
Sepsis
Eligibility:
All Genders
18-99 years
Brief Summary
Background: Sepsis is one of the most common reasons for admission to intensive care units (ICU) worldwide. About 30% of all patients admitted to intensive care suffer from sepsis (1). Sepsis causes ...
Detailed Description
Background: Sepsis is one of the most common reasons for admission to intensive care units (ICU) worldwide. About 30% of all patients admitted to intensive care suffer from sepsis (1). Sepsis causes ...
Eligibility Criteria
Inclusion
- Patients admitted to the ICU between 1.1.2014-30.1.2020. 2. Diagnosis of sepsis or septic shock upon admission. 3. Age over 18 years. 4. No previous diagnosis of diabetes mellitus.
- \-
Exclusion
- Patients with prior diagnosis of diabetes mellitus. 2. Admission hypoglycemia (blood glucose levels below 70 mg / dL). 3. Patients who were given insulin or intravenous glucose before the first ICU blood glucose measured level.
- \-
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT04740333
Start Date
December 1 2023
End Date
February 1 2024
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel